Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Pentoxifylline in Diabetic Nephropathy
IRCT20190806044451N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Zanjan University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20190806044451N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190806044451N2.